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Introduction
MRI plays an integral role for diagnosis and monitoring of MS due to its sensitivity for the depiction of focal lesions, which are characteristically present in the brain and spinal cord of MS patients [1] [2] [3] [4] . The ability to assess efficacy of new disease modifying treatments relies on the identification of new T 2 -hyperintense lesions, and the detection of inflammatory lesion activity 3, [5] [6] [7] . However, detection and accurate demarcation of MS lesions on MRI is challenging due to heterogeneity in lesion location, size and shape in addition to anatomical differences between subjects 8 and therefore requires expert knowledge. Manual lesion segmentation is laborintensive, time-consuming and subject to intra-and inter-expert variability [8] [9] [10] [11] . Recent supervised automated lesion segmentation methods have shown potential to provide lesion masks that closely match the manual expert segmentations 12, 13 , e.g. by utilizing neuronal networks, but rely on large training data sets, which are often not readily available. The need for training in supervised segmentation approaches and empirical selection of tuning parameters has hampered widespread application and validation of these tools, and complicated their use particularly in small scale studies. In depth discussions of different supervised and unsupervised methods are presented in reviews by García-Lorenzo et al. 8 , Lladó et al. 14 and Sweeney et al. 15 . For widespread clinical and research applicability, lesion segmentation tools should be publicly available and ideally function without manual fine-tuning of processing parameters to facilitate reproducibility.
Thus, publicly available, automated methods that require no or minimal training data are of interest, including LesionTOADS 16 , the Lesion Segmentation Toolbox (LST) 17 , Salem Lesion Segmentation (SLS) 18 , or Automated Statistical Interference for Segmentation (OASIS) 19 , which have been widely applied in reference to other lesion segmentation approaches 12, 13, [20] [21] [22] [23] [24] . In particular, LesionTOADS and LST provide ample reference for their lesion segmentation A C C E P T E D M A N U S C R I P T performance. Both are available as cross-platform software packages; LesionTOADS as a plugin to the Java-based MIPAV toolbox, and LST as a plug-in to SPM, run within MATLAB.
Notably, LesionTOADS also provides a segmentation of brain tissues, a functionality that extends its use to cortical segmentations and atrophy assessments 25, 26 . Therefore, LesionTOADS has also found widespread application in clinical research of MS 27, 28 and beyond 29 .
Nonetheless, automated segmentation approaches are also challenged by the heterogeneous MR appearance of MS lesions and therefore generally unable to match manual or semi-automated lesion definitions 8 . Thus, semi-automatic segmentation methods, e.g. automated, user-controlled region growing approaches based on manually placed seed points 30 , continue to remain the standard in clinical studies and provide the reference for newer, automated techniques.
Noteworthy, supervised as well as unsupervised segmentation methods are often tested on small, single-site, homogenized imaging data 8 , which do not correspond to the real-world application of these approaches to multi-center, often multi-vendor data sets.
Here, our objective was to test the performance of LesionTOADS in a multi-center clinical trial using non-homogenized 2D-imaging data. We further investigated whether LesionTOADS segmentation benefits from the use of FLAIR 2 , a new contrast recently suggested to aid in automated lesion segmentation methods. FLAIR 2 images are obtained through multiplication of co-registered 3D-T 2 weighted and 3D-FLAIR images, both standard in MS imaging protocols 31 .
The combination of T 2 and FLAIR, referred to as FLAIR 2 , has shown to improve tissue contrastto-noise, while simultaneously suppressing CSF 32 . Thus, FLAIR 2 may aid automated lesion segmentation methods, potentially also in cases of lower field strengths and non-3D image acquisitions.
The performance of LesionTOADS, when applied to FLAIR 2 in comparison to FLAIR in the multi-center study, was compared in a secondary analysis with the segmentations obtained from
OASIS, a segmentation package publicly available within R, and LST for the same data set.
Lastly, we contrasted our findings with the application of LesionTOADS to data obtained from a single-center, homogenized imaging study, in the challenging setting of low lesion load volumes in patients with clinically isolated syndrome (CIS).
Methods & Materials

Demographics
MRI scans from a cohort of 47 relapsing-remitting MS patients, randomly selected from a multicentre clinical trial performed at 34 different scanning sites, were included in this study. The second cohort consisted of 40 CIS, scanned at baseline at a single-site, prior to treatment randomization in a clinical trial (NCT00666887).
All patients gave written informed consent. Due to the blinded nature of the data analysis in these trials, no further demographic information was available.
MR image acquisition and processing
2D-FLAIR, 2D-T 2 w, 2D-Proton Density weighted (PDw), and 3D-T 1 -weighted (T 1 w) scans with a variety of acquisition parameters were selected in the multi-center study in order to reflect the range of values used in MS imaging studies. All scans were acquired at a voxel size of 0.94 x 0.94 mm 2 and 3.00 mm slice thickness, at either 1.5 and 3T, except for T 1 w-images, which were acquired with voxel sizes varying between 0.94 x 0.94 mm 2 to 1 x 1mm 2 and slices of 1 or 1.5 mm thickness. For all T 2 w, FLAIR and PDw-scans, 60 slices were acquired, while T 1 w-images were acquired with more slices due to their reduced slice thickness (between 116 and 208).
Detailed scan parameters for the multi-center study are provided in Supplementary Table 1 . All data concerning the single-center study were acquired at a 3T Philips Achieva. The voxel size
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was the same as in the multi-center study, 0.94 x 0.94 x 3 mm, for all image contrasts. Dual-echo   PD/T 2 w images were acquired at TE 1 =8.4 ms, TE 2 =80 ms, TR=2800 ms; FLAIR images used   TE = 125 ms, TR = 11 s, TI = 2800 ms, refocusing flip angle = 125°; and spin-echo T 1 w images were acquired at TE = 10 ms, TR = 657 ms and flip angle = 50°.
For both studies, a bias correction was performed on all images using the revised N3 technique as described by Jones and Wong 33 , prior to further processing. The revised N3 techniques captures areas of steep inhomogeneity gradients, which are not fully corrected with N3 alone.
All images, T 1 , T 2 and FLAIR, were co-registered to the PDw-image space and brain extracted prior to LesionTOADS segmentation using FLIRT and BET, tools of the FSL software library 34, 35 . For the purpose of the FLAIR 2 image computation, FLAIR scans were also coregistered to the T 2 w images as described in Wiggermann et al. 32 The aligned FLAIR and T 2 wscans were then multiplied, yielding the FLAIR 2 image, and subsequently mapped to PDw for lesion segmentation.
Semi-automated reference segmentation
Lesions identified by the semi-automatic method described in McAusland et al. 30 were used in both studies for comparison with LesionTOADS, OASIS and LST. A neuroradiologist identified lesions consistent with MS pathology on T 2 w-and PDw-scans and marked each lesion with a minimum of one lesion point. A technician then performed the semi-automatic growing process to create the reference lesion mask.
LesionTOADS
LesionTOADS is a topology-preserving segmentation tool 16 designed to identify and segment white matter (WM) MS lesions while simultaneously classifying other brain tissues. Since
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LesionTOADS is optimized for FLAIR and T 1 w-images, T 1 w-images were included in addition to FLAIR or FLAIR 2 , respectively. All LesionTOADS parameters remained at default, for both the FLAIR and FLAIR 2 image segmentation. The default parameters are listed in Inline Supplementary Table 2 . For this work, the 2014 R4c version of TOADS CRUISE was downloaded from NITRC on September 28 th 2018 and run within MIPAV version 7.0.1.
OASIS
OASIS uses logistic regression to estimate the voxel-level probability of lesion presence based on the voxel intensities on T 1 w, T 2 w, PDw and FLAIR images 19 . In contrast to LesionTOADS, OASIS uses the T 1 w-image space as reference and performs a non-linear registration to the MNI standard space using FSL tools. The user may provide original, unprocessed or pre-processed images for OASIS processing. In order to take full advantage of its pipeline, we used non coregistered, non-brain extracted images for OASIS. Although OASIS masks brain tissues from CSF prior to lesion detection, it does not yield further tissue class segmentations. The OASIS pipeline provides an already trained segmentation model, based on 15 MS patients and 5 healthy controls. However, study specific thresholding is recommended and study data training is possible. For best results of OASIS, we trained a model on four data sets from our study, for 
Performance evaluation
We computed the commonly used relative lesion volume difference (LVD), the Dice coefficient (DSC), sensitivity (SEN) and the symmetric surface distance (SSD) to assess the performance of FLAIR versus FLAIR 2 for the different segmentation algorithms and studies. LVD represents the relative volume difference between the LesionTOADS, OASIS or LST and reference lesion segmentation. To assess the overlap between segmented lesion voxels, not captured by LVD, DSC and SSD were computed. SSD reflects the closeness of border voxels of the segmentation and the reference, while the DSC assesses the number of true positive lesion voxels compared to false positive and negative voxels. Additionally, SEN, another overlap measure which focuses only on the amount of true positive and false negative voxels, was estimated. All performance metrics are detailed in Table 1 . In a secondary analysis, we stratified patients based on their absolute detected reference lesion volume (LV) and categorized them accordingly as patients of high (> 15 cm 3 ), medium/low (> 5 cm 3 & < 15 cm 3 ) or minimal LV (< 5 cm 3 ) to test for performance variation. For comparison with other studies, these volume thresholds were adapted from literature 17, 20 . 
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Statistical Analysis
All performance evaluation indices were calculated separately for each segmentation tool based on FLAIR and FLAIR 2 against the semi-automated reference. In addition, the mean difference between the FLAIR and FLAIR 2 scores as well as the relative improvement score (mean diff /mean FLAIR ) for each metric were computed. Significance of the improvement was determined using a paired t-test. Furthermore, a mixed effects model was implemented in R (lme4 package 36 ) to assess statistical differences in regard to the chosen input image
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(FLAIR/FLAIR 2 ) and the effect of LV for the multi-center study. The fixed model parameters were complemented with two random effects, addressing site and patient variability. The site parameter accounts for segmentation differences related to the site-specific imaging protocols in the multi-center study. Ultimately, pairwise multiple comparisons for the performance indices based on LV and the use of FLAIR or FLAIR 2 were assessed using the lsmeans package 37 , which performs a post-hoc Tukey's HSD test and p-value adjustment. Since the difference in segmentation performance between FLAIR and FLAIR 2 was mainly of interest, we did not statistically evaluate the performance differences between LesionTOADS, OASIS and LST.
Results
One patient's FLAIR image was incorrectly reconstructed with non-zero signal outside of the brain, and thus no FLAIR 2 i ge co l be obt i e . A othe p tie t's LAI i ge exhibited strong motion-induced inter-slice misalignment 38 , which prevented co-registration between FLAIR and T 2 w. For the multi-center study, LesionTOADS failed to complete processing for two subjects on both the FLAIR and FLAIR 2 image. These data sets were excluded from further analysis, in addition to one data set for which no information about the imaging parameters and field strength was available. Of the remaining 42 multi-center patients, 40 had been scanned at 1.5T at 30 different sites and two data sets had been obtained at 3T from one site. compared to the semi-automated reference segmentation ( Fig. 2A ). However, FLAIR 2 significantly improved LV estimates compared to using FLAIR alone (p = 0.018, relative improvement 31.6%). In particular, we noticed an improved segmentation for LVs > 10 cm 3 when using FLAIR 2 compared to FLAIR, although a correct estimation of large LVs appears to be more challenging as noted by the increasing discrepancy between the LesionTOADS and reference segmentation estimated LVs.
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A C C E P T E D M A N U S C R I P T LesionTOADS, segmentation based on FLAIR 2 scored significantly higher than FLAIR in three of the four indices: LVD: mean diff = -0.2 a.u. (p = 0.018); DSC: mean diff = 5.2% (p = 0.19) with a relative improvement of 14%; SEN: mean diff = 6.98% (p = 0.048) with a relative improvement of 25.1%; SSD: mean diff = -3.5 mm (p = 0.0097), with the largest relative improvement of 47%.
A C C E P T E D M A N U S C R I P T To assess whether these improvements are specific to the use of FLAIR 2 within LesionTOADS, we applied the OASIS segmentation pipeline as well as LST to the same data set. A side-by-side comparison of the LesionTOADS, OASIS and LST segmentation performance, relative to the semi-automated reference, is shown in Figure 3 . Mean scores and relative improvements are summarized in Table 2 .
DSC showed little discrepancy between the different segmentation approaches as well as between FLAIR and FLAIR 2 , hence yielding the lowest relative improvements of all performance scores. OASIS showed more variability in LVD ad SSD, achieving on average lower performance than LesionTOADS in these two scores. LST similarly varied more in LVD and SSD, but this variability and the lower performance were limited to FLAIR 2 . One exception is SEN, which was notably higher for both OASIS and LST. Comparison of FLAIR and FLAIR 2 with LST replicated the significant improvement in SEN seen with LesionTOADS (p = 0.031), however, SSD was significantly lower when using FLAIR 2 compared to FLAIR (p = 0.0002).
Pairwise comparison of the OASIS scores obtained using FLAIR and FLAIR 2 yielded no significant differences (LVD p = 0.38, DSC p = 0.91, SEN p = 0.43, SSD p = 0.32), although LVD and SSD showed relative improvements for FLAIR 2 over FLAIR similar to LesionTOADS (LVD 55.8%, SSD 21.8 % improvement).
A C C E P T E D M
A N U S C R I P T Since the average performance of LesionTOADS, as well as OASIS and LST, was lower than reported in previous studies (e.g. mean DSC < 42.2%, see Table 2 , compared to 16, 19 ), we further investigated the effects of LV under varying acquisition parameters in the multi-center imaging study. The performance scores for LesionTOADS are summarized in Figure 5 . LVD (Fig. 5A) and SEN (C) improved in FLAIR 2 -based segmentations largely independent of LV. This was confirmed by the linear mixed effects model, which showed no significant effect of LV stratification nor an interaction between the two grouping factors (input MR sequence and LV, p > 0.09). Pairwise post-hoc comparisons demonstrated a significantly improved LVD when using FLAIR 2 over FLAIR at minimal LV (p = 0.043) as well as significant improvements in SEN at low/medium and high LV (p = 0.0007 and p = 0.002, respectively). improved LVD (p = 0.043) and SSD (p = 0.044).
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
In contrast, DSC (B) and SSD (D), albeit insignificantly so for SSD, changed with LV for FLAIR 2 . Similar, but insignificant trends were observed for FLAIR. Both, DSC and SSD,
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indicated that FLAIR 2 -segmented data sets with larger LVs showed greater comparability to the reference segmentation. This is reflected in the smaller standard deviations for FLAIR 2 at greater LVs noted for DSC and SSD in Fig. 5 , but also represented in Fig. 2B , where FLAIR 2 segmentation for LVs > 5cm 3 consistently achieved DSC scores > 30 %, while some FLAIRbased LesionTOADS lesion masks continued to exhibit little similarity to the reference.
Mean and standard errors for all metrics for LesionTOADS, when stratified by LV, are summarized in Table 3 . In addition, examples of the segmentation performance of LesionTOADS at different LVs are displayed in Figure 6 . ig ific t l es e highlighte i bol fo t. Notably, the significant improvement in SSD for minimal LV was maintained, although data sets with minimal LVs were overall poorly segmented. LST (right) showed similar LV-dependent improvements in DSC, and a stronger effect of SEN on LV than observed with LesionTOADS or OASIS. LVD and SSD were LV-independent for FLAIR-based segmentations, but showed large improvements for FLAIR 2 . Although FLAIR 2 performed similar or better (SEN) than FLAIR when LVs passed 5 cm 3 , small LVs segmentations with LST performed significantly poorer with FLAIR 2 compared to FLAIR. Within the limited scope of 3T data available within the multi-center study (n = 2 versus n = 40 for 1.5T), the mixed effects model suggested no significant effect of field strength on the outcomes, except for SSD (p = 0.02), with worse performance at 3T.
LV < 5 cm
To test the performance of LesionTOADS at higher field strength and in the challenging setting of lower LVs, we used LesionTOADS to segment data in a CIS single-site data set, again using FLAIR and FLAIR 2 . The performance is summarized in Figure 8 . 
Discussion
We demonstrated that by combining FLAIR and T 2 w images prior to selecting them as input for LesionTOADS, MS lesion segmentation in lower-field strength, multi-center studies may be enhanced by 14 -47%, depending on the performance evaluation score. Since 
Multi-center study
Previously, the value of FLAIR 2 was demonstrated using 3D-FLAIR and 3D-T 2 w acquired at 3T 32 . Based on 5 healthy controls and 7 MS patients, a 133% increase in contrast-to-noise between gray matter vs. WM and 158% for lesions vs. WM was observed when using FLAIR 2 over FLAIR. It was furthermore described that the gain in signal-to-noise ratio (SNR) in 3Dacquisitions compared to 2D-scans allowed for the acquisition of isotropic voxels, providing robust image registration and permitting image reformatting. For this study, FLAIR 2 was computed from 2D-scans as 2D-data acquisitions have been, until recently, the standard in clinical trials and clinical practice. We demonstrated that 2D-FLAIR 2 provides significantly improved lesion segmentation with LesionTOADS, even when most data were collected at 1.5T
using non-homogenized image acquisition protocols. While the 2D-results do not necessarily predict the success of LesionTOADS for 3D-imaging data, the SNR gain suggests further improvements.
LesionTOADS
Overall, LesionTOADS underestimated the LV in our data set, even with FLAIR 2 . We performed the segmentation with default parameters; optimizing the parameters and/or
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modifying the software may increase performance for both scans, however, this was not the purpose of this work. If modified, LesionTOADS may also arguably not be classified as an unsupervised segmentation method, although much fewer data sets would be required to optimize performance than needed for deep learning machines. FLAIR 2 -LesionTOADS with default parameters seemed to detect the central, most hyperintense parts of MS lesions, but omitted areas that appeared more diffusely damaged as well as lesion boundaries and lesions that were not periventricular and appeared less hyperintense (Fig. 1) . In contrast, the T 2 and PDbased semi-automated segmentation, commonly used for clinical trials, provided a reference closer to the ground truth 30 by more fully capturing the extent of MS lesions. Our data showed that although large LVs will be incompletely captured, even by FLAIR 2 , the areas that are detected by LesionTOADS are in good correspondence to the reference. The extent of smaller LVs was better described, but lacked in overlap to the reference as noted by low DSC and large SSD scores. By using FLAIR 2 , LVD improved to under 0.5 (LVD FL 2 =0.436), which is higher than LesionTOADS achieved in the lesion segmentation challenge 39 , possibly owing to the fact that the present examined data were low field strength, multi-site, employing non-homogenized acquisition protocols. The low DSC and SEN scores agree with other multi-center studies 21 , while a single-site, homogenized imaging study has previously achieved better mean DSC scores of up to 61% 20 . However, improvements with respect to LV were comparable. The aforementioned study reported a 15% change in DSC between small and larger LVs, in line with the 20% improvement in our study when using FLAIR 2 . Note also that deep learning tools currently achieve sub-optimal DSC scores of 63% 40 . Thus, automated segmentation approaches, like LesionTOADS, may be currently favored given their minimal need for training data.
OASIS
A C C E P T E D M A N U S C R I P T
In contrast to LesionTOADS, performance of OASIS did not improve when using FLAIR 2 instead of FLAIR for the segmentation. OASIS did perform less consistent than LesionTOADS for the same data, particularly at lower LVs, introducing larger heterogeneity in the achieved LVD and SSD segmentation scores. Regardless of the larger variance in segmentation performance that might limit statistically significant findings, OASIS likely benefited less from FLAIR 2 , since it already utilized the input of T 2 w and FLAIR in addition to T 1 w and PDw. Thus, various T 2 -weightings were already included in OASIS, even when using FLAIR. Using multiple imaging modalities for MS lesions segmentation agrees with the heterogeneous presentation of MS lesions. Automated lesion segmentation approaches, however, rely often on few modalities, e.g. T 1 and FLAIR only [16] [17] [18] 20 . Incorporating other, possibly quantitative modalities, as attempted in the MS Lesion Segmentation Challenge, which provided diffusion tensor imaging data 11 
LST
LST also over-segmented lesions, albeit less so than OASIS, largely sparing diffuse hyperintense regions. Thus, SEN was higher than for LesionTOADS, but all other scores indicated similar performance. Notably, LST replicated the significant improvement in SEN of FLAIR 2 over FLAIR. In contrast, SSD for FLAIR 2 -LST was significantly higher than for FLAIR and higher than observed with LesionTOADS. This pattern was more apparent when investigating the performance of LST relative to LV. The deficiency for accurate segmentation of small LVs with The multi-site data acquisition, while a drawback, is also a strength of our study. For the 2013 review 8 of 47 MS lesion segmentation approaches, 11 used the two-site data provided for the MS lesion segmentation challenge 11 and only two validated their methods using multi-centre data.
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Moreover, the 42 and 39 data sets included here exceed the cohort size of most of these publications; 29 studies had 20 data sets or less in their analyses and the largest cohort comprised 41 patients. We demonstrated in this larger, multi-center cohort that by changing the input image contrast used by LesionTOADS, lesion segmentations were significantly improved in this realworld setting. While other tools need to be optimized to handle amplified hyperintensities appearing on FLAIR 2 , FLAIR 2 already performed similar or better in some cases than FLAIR.
CIS single-center study
To test whether LesionTOADS in combination with FLAIR 2 also enhanced segmentation performance at higher field strength, we applied LesionTOADS to 40 data sets of CIS patients acquired at 3T. Note that this data did not overlap with the 3T data from the multi-center study.
In this data set, LesionTOADS-FLAIR 2 did not demonstrate benefits over FLAIR. Notably, the data set included primarily patients with minimal LVs, on average less than half of the LV detected in the multi-center MS cohort. As shown, LesionTOADS performance improved with increasing LV, thus DSC was low and LVD and SSD were high, in agreement with the scores presented for the minimal LV group in Fig. 5 . Notably, using LesionTOADS un-optimized for small LVs, may lead to an overestimation of LVs, if the true LV is small 21 LesionTOADS may be able to address these issues partly by specifying the distance between lesion voxels and cortex as well as ventricles. However, improving the WM segmentation that is performed within LesionTOADS rather than relying on parameter tuning will provide a more generalized and standardized approach to segmentation improvement. Note also that albeit the reference ground truth, manual or semi-manual expert segmentation will also be image contrast dependent and can be prone to errors. Enhanced FLAIR 2 -hyperintensities may be missed, as shown in Fig. 8 , where the center of the large lesion remained undetected. This may be considered an inherent property of LesionTOADS and its fuzzy C-means clustering. In case that a voxel presents very high intensity on FLAIR 2 , it may be far from any centroid in the clustered space and may thus produce equal, unpredictable memberships. This may in part explain the continued under-segmentation of LV by means of LesionTOADS segmentation, despite the improved contrast-to-noise of FLAIR 2 . A pre-processing step could be applied to threshold the intensities of FLAIR 2 , prior to LesionTOADS segmentation.
Limitations
We focused our study on LesionTOADS, one of the publicly available automated segmentation tools that had been previously evaluated in the 2008 MS Grand Segmentation Challenge 11 . Other segmentation tools may benefit even more, or possibly less from the combination of FLAIR and T 2 as shown here for example with OASIS and LST. Publicly available, state-of-the-art lesion segmentation tools have been widely compared, however, depending on the evaluation score, assessments vary broadly.
Among the publicly available tools, Souplet's approach 41 ranked highest in the initial challenge just above LesionTOADS indicating high similarity in their performance 14 . Although Cabazas et al. 42 showed that LST outperformed Souplet's method, as assessed by DSC and SSD, which
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would therefore suggest a better performance than LesionTOADS, Jain et al. 20 in fact, showed that on average LesionTOADS had greater precision and achieved higher DSC than LST, with equal SEN. Moreover, LST yielded considerably lower DSC scores at LV < 5 cm 3 than
LesionTOADS. Noting that approximately one third of our patients in the multi-center study and 72.5 percent of patients in our single-center study had LVs < 5 cm 3 , using LST may be suboptimal, although it was shown to provide the most comparable LV estimates. Notably, our data showed comparable LVD and DSC scores at small LVs between these two segmentation tools. However, LesionTOADS-FLAIR 2 improved LVD in our multi-center study compared to FLAIR significantly at LVs < 5 cm 3 (p = 0.043), while retaining performance on all other scores.
SLS performed better than LesionTOADS in the detection of FP lesion voxels and in terms of volume differences, while LST achieved superior segmentation accuracy 12 . For this study, LesionTOADS was chosen because it was readily available, its comparable and favorable performance, and because it provides ample reference for comparisons 12, 19, 20 . LesionTOADS moreover provides the benefit of simultaneous tissue segmentation, not available using most other segmentation methods, and does not require costly licenses, a possibly limiting factor for accessibility to some tools, e.g. such as implemented within SPM/Matlab.
Evaluation metrics
A wide range of parameters exists that can be used to assess the quality of segmentations with respect to a reference. DSC and SEN are the most frequently used 14 , but other scores such as the lesion-wide TP or FP rates may need to be considered when determining the segmentation precision of small lesions in the cortex or the deep WM, where partial volume effects play a larger role. 8 Although the same T 1 w-images were used in combination with FLAIR and FLAIR 2 , the contrast combination of the two input images will ultimately determine the success of
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LesionTOADS. The default parameters, which were employed in our study, that work optimally for the T 1 -FLAIR input, may not be ideal for T 1 -FLAIR 2 . Double inversion recovery (DIR) is currently suggested to be the most suitable sequence for the detection of cortical lesions, which are generally not captured by lesion segmentation algorithms, but suffers from limited SNR with relatively long data acquisition times 43 . FLAIR 2 provides image contrast similar to DIR at a higher spatial resolution and with improved SNR and contrast-to-noise 32 . Fig. 1C demonstrates the enhanced contrast of the cortical gray matter, which could provide a starting point for cortical lesion segmentation, particularly at higher field strength.
Overall, our study suggests that the computation of FLAIR 2 is particularly beneficial if the image quality of FLAIR itself is lower, possibly due to lower SNR at lower field strength as observed in our multi-center study. Whether FLAIR 2 will be beneficial at higher field strength remains to be shown. Improved WM delineation and adjustments of the FLAIR 2 image intensity may be needed to take full advantage of the benefits of FLAIR 2 in LesionTOADS as well as with other segmentation tools.
Conclusion
The computation of FLAIR 2 from FLAIR and T 2 w images increases the performance of automated lesion segmentation with LesionTOADS at minimal additional scan time or computational cost, in the setting of multi-center, lower field strength non-homogenized 2D-data acquisitions. As long as both FLAIR and T 2 w-scans are available, whether acquired 2D or 3D, 
